PollenVax Shot for Mugwort Pollen Allergies
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new allergy shot (PollenVax) given under the skin to treat seasonal allergies caused by mugwort pollen. If you have moderate-to-severe mugwort allergies confirmed by testing, this trial may help reduce your symptoms during pollen season.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–65 years old
- Diagnosed with moderate-to-severe mugwort pollen allergies lasting at least 2 years, confirmed by skin or blood testing
- Able to attend all study visits and keep a daily symptom diary
- No prior allergy shots to mugwort or other allergens in the last 3 years
- No severe or uncontrolled asthma, and no life-threatening allergic reactions in your history
- Stable overall health (no active serious infections, heart disease, liver disease, kidney disease, or cancer)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.
This Phase 3 trial tests whether an allergy treatment can reduce symptoms caused by grass and olive pollen. It also checks safety, especially for breathing and allergic reactions, in people with confirmed grass/olive allergy.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This study checks how well a newer, detailed allergy test (using specific allergen components) can guide whether you should get allergy immunotherapy (allergy shots) for things like dust mites or grass pollen. It may help patients get the right treatment plan by improving how doctors confirm what allergens are driving symptoms.
This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.
This study tests if adding vitamin D to a new type of allergy shot (ILIT) works better than standard allergy drops for grass pollen allergy. It may help if you have moderate to severe seasonal allergy symptoms.
Hear when a new Rhinitis Allergic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.